20 January 2019

My name is Febrina Meutiawati and I am Indonesian. I’m currently pursuing my PhD in Medical Microbiology Department, at the Experimental Virology Group, Theme Infectious diseases and global health.

When you were a kid what did you want to be when you grew up? Can you tell us something about your child years. 

Since my mother is a teacher in physics, being a teacher was one of my dreams. Besides that, I remembered that I was more interested in life science subjects rather than social and literature subjects. However, as a kid, I was clueless on what scientists do. I only knew one scientist (sadly, a fictional character), dr. Dana Scully. Thanks to the TV series, I gained my interest to the scientific world.

What was your previous academic training, where did you study and why that study? 

I got my Bachelor and Master degree on Chemistry and Biochemistry from Bandung Institute of Technology. I was impressed by the scope of chemistry subject which is basically related to everything; physics, biology, medicine and even sometimes philosophy. Therefore, I chose to study the subject. Over time, my interest was more focus on molecular biology and was broaden to virology because there I can understand the molecular mechanism of disease in general, and viruses in specific. Moreover, cell culture works and plaque assays are quite exciting!

The RIMLS motto is: ‘Today’s molecules for tomorrow’s medicine’. What does this mean for you? 

The motto basically represents the general topic of my PhD projects of which focus on discovery of antiviral drugs for mosquito-borne viruses. Our approach is by repurposing the collection of small drug-like compounds for antiviral activity screening to identify ones that inhibit dengue virus. Therefore, for me personally, this means every data matters, no experiment goes in vain. Our today’s pointless results may become very useful someday.

Who is your great example as scientists? And please give a motivation why.

I actually use everyone as great examples, and as scientists, I learned a lot from my supervisors and colleagues. However, I am greatly motivated by Dr. Angelle Desiree LaBeaud because she’s one of the myth-breakers of motherhood in science. This year, she received a Woman in Science Award  given by International Society of Antiviral Research for her contribution in investigating the epidemiology of arboviral infection, in particular her dedication in arbovirus research in Kenya. From her experience, I can learn that there is a possibility to have an elevating career in science without having to choose between family and work. 

Which research discovery that you have made has made you most proud? 

I’m currently working on the discovery of novel antiviral drugs for dengue virus, one of the most pathogenic mosquito-borne virus. One discovery that I contributed to (of which i’m very proud of) is identification of the target from one of our antiviral drug candidates, posaconazole. Moreover, the host target that we identified was never been reported to be involved in dengue virus replication mechanism before. Therefore, besides identified the target of posaconazole for its inhibition activity against dengue virus, we also found a potential host target that can be a candidate for further antiviral drug development. 

Given unlimited finance what experiment would you perform?

Of course, clinical trials of the dengue antiviral drug candidates that have been successfully characterized. Besides that, I’d like to build a research center focusing on antiviral drug screening and characterization on natural sources in Indonesia.

What does your working area (desk, office) look like and what does it say about you (or your research)? 

It’s intermediate, I’d say. Not so tidy yet not so messy. I’m not entirely sure what it says about my research, though. However, if you happen to see my desk super clean, that means I’m either on holiday or  in a serious stress.

Nominate a colleague to be in the spotlight and what would you like to ask him or her?

Bodine Bezemer. If you only have two options to survive in this world: listening to the whole album of Kensington every single day or make 100 types of replicon ….. stable cell lines, which one will you choose?

What type of person are you, quick insights:

a) Mac or PC?                                : Mac
b) Theater or cinema?                 : Cinema
c) Dine out or dine in?                 : Dine in
d) Ferrari or Fiat?                         : Neither
e) Shopaholic or chocoholic?     : Shop-a-choco-holic
f) Culture or Nature                     : Nature

Related news items


4,8 million euros for prevention of tuberculosis among people with diabetes in Africa

16 July 2019

Reinout van Crevel and Lindsey te Brake have received European funding of 4.8 million euros to lead an international consortium to screen thousands of people with diabetes in Uganda and Tanzania for TB, and investigate the effect and costs of 3 months preventive treatment for TB.

read more

50.000 grant for Paul de Jonge and Harry Dolstra

15 July 2019

Paul de Jonge and Harry Dolstra, theme Cancer development and immune defense, received a €50.000,- (NWA-IDG) grant for their project regarding cancer immunotherapy.

read more

Handbook of biomarkers and precision medicine a new publication by Alain van Gool

12 July 2019

Alain van Gool published a new handbook on biomarkers and applications in (pre)clinical drug development for precision medicine.

read more

Successful Summer School by CMBI, TML and Human Genetics

8 July 2019

CMBI, TML and Human Genetics organized a successful Summer School on 'Integrative X-omics Analyses Empowering Personalized Healthcare'.

read more

Summer greetings from René Bindels

5 July 2019

In this last newsletter before the summer break and before I wish you all a happy holiday, I would like to briefly summarize the first half of 2019 and especially look ahead to the interesting activities that will take place in the second half of the year.

read more

Prostate cancer theranostics imaging, surgical guidance, and targeted photodynamic therapy

5 July 2019

In Theranostics, Mark Rijpkema and colleagues present the development of a novel multimodal tracer that targets both preoperative imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing prostate cancer.

read more